Suchergebnisse - "Brain/metabolism [MeSH]"

  1. 1
  2. 2

    Quelle: Eur J Nucl Med Mol Imaging
    Sobek, Jens; Li, Junhao; Combes, Benjamin F; Gerez, Juan A; Henrich, Martin T; Geibl, Fanni F; Nilsson, Peter R; Shi, Kuangyu; Rominger, Axel; Oertel, Wolfgang H; Nitsch, Roger M; Nordberg, Agneta; Ågren, Hans; Ni, Ruiqing (2024). Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein. (In Press). European journal of nuclear medicine and molecular imaging Springer 10.1007/s00259-024-06806-7 <http://dx.doi.org/10.1007/s00259-024-06806-7>
    Sobek, Jens; Li, Junhao; Combes, Benjamin F; Gerez, Juan A; Henrich, Martin T; Geibl, Fanni F; Nilsson, Peter R; Shi, Kuangyu; Rominger, Axel; Oertel, Wolfgang H; Nitsch, Roger M; Nordberg, Agneta; Ågren, Hans; Ni, Ruiqing (2024). Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein. European journal of nuclear medicine and molecular imaging, 51(13), pp. 3960-3977. Springer 10.1007/s00259-024-06806-7 <http://dx.doi.org/10.1007/s00259-024-06806-7>
    European Journal of Nuclear Medicine and Molecular Imaging, 51 (13)

    Dateibeschreibung: application/pdf; application/application/pdf; ZORA_260747.pdf - application/pdf

  3. 3
  4. 4

    Quelle: J Neurol
    Journal of neurology 271(8), 5290-5300 (2024). doi:10.1007/s00415-024-12388-z

    Schlagwörter: Male, Grey matter volume, Neuropsychological Tests, diagnostic imaging [Cognition Disorders], Cerebral glucose metabolism, Cognition, Mental Disorders/metabolism [MeSH], Aged [MeSH], Magnetic Resonance Imaging [MeSH], Male [MeSH], Positron-Emission Tomography [MeSH], Glucose/metabolism [MeSH], Cognition Disorders/diagnostic imaging [MeSH], Female [MeSH], Amyotrophic lateral sclerosis, Brain/diagnostic imaging [MeSH], Fluorodeoxyglucose F18/metabolism [MeSH], Cerebral Cortex/metabolism [MeSH], Humans [MeSH], Middle Aged [MeSH], Amyotrophic Lateral Sclerosis/metabolism [MeSH], Amyotrophic Lateral Sclerosis/diagnostic imaging [MeSH], FDG-PET, Cognition Disorders/metabolism [MeSH], Cerebral Cortex/diagnostic imaging [MeSH], Brain/metabolism [MeSH], Mental Disorders/diagnostic imaging [MeSH], Cognition Disorders/etiology [MeSH], Original Communication, Neuropsychological Tests [MeSH], diagnostic imaging [Amyotrophic Lateral Sclerosis], Fluorodeoxyglucose F18, metabolism [Cognition Disorders], diagnostic imaging [Cerebral Cortex], metabolism [Fluorodeoxyglucose F18], Humans, ddc:610, diagnostic imaging [Brain], Aged, Cerebral Cortex, metabolism [Amyotrophic Lateral Sclerosis], metabolism [Cerebral Cortex], Mental Disorders, Amyotrophic Lateral Sclerosis, etiology [Cognition Disorders], Brain, Middle Aged, Magnetic Resonance Imaging, 3. Good health, metabolism [Glucose], Glucose, metabolism [Brain], Positron-Emission Tomography, Female, Cognition Disorders, metabolism [Mental Disorders], diagnostic imaging [Mental Disorders]

  5. 5

    Weitere Verfasser: Le Grand, Quentin Tsuchida, Ami Koch, Alexandra et al.

    Quelle: Mol Psychiatry
    Molecular psychiatry 29(11), 3567-3579 (2024). doi:10.1038/s41380-024-02604-7

    Dateibeschreibung: application/pdf

  6. 6

    Quelle: Mol Psychiatry
    Molecular psychiatry 29(11), 3537-3552 (2024). doi:10.1038/s41380-024-02598-2

    Dateibeschreibung: application/pdf

  7. 7
  8. 8

    Quelle: Mol Psychiatry
    Molecular psychiatry 29, 3151-3159 (2024). doi:10.1038/s41380-024-02577-7
    Molecular Psychiatry

  9. 9

    Quelle: Mol Psychiatry
    Molecular psychiatry 29(10), 2997-3009 (2024). doi:10.1038/s41380-024-02559-9
    Molecular Psychiatry

    Dateibeschreibung: application/pdf

  10. 10

    Quelle: Mol Psychiatry

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Quelle: J Neural Transm (Vienna)

    Dateibeschreibung: application/pdf

  16. 16
  17. 17

    Quelle: Eur J Nucl Med Mol Imaging
    European journal of nuclear medicine and molecular imaging 51(4), 1035-1049 (2024). doi:10.1007/s00259-023-06530-8
    European Journal of Nuclear Medicine and Molecular Imaging, vol 51, iss 4

    Schlagwörter: Florbetapir-PET, Aging, Apolipoprotein E4, Clinical sciences, genetics [Alzheimer Disease], Neurodegenerative, Alzheimer's Disease, metabolism [Cognitive Dysfunction], 2.1 Biological and endogenous factors, genetics [Apolipoprotein E4], Aniline Compounds, Original Article, Myelin, Tau, APOE, Medical and Health Sciences, Brain, 16. Peace & justice, ddc, Other Physical Sciences, Nuclear Medicine & Medical Imaging, Neurological, Cognitive Dysfunction/metabolism [MeSH], Demyelinating Diseases/metabolism [MeSH], Amyloid beta-Peptides/metabolism [MeSH], Humans [MeSH], Aniline Compounds [MeSH], Alzheimer Disease/diagnostic imaging [MeSH], Brain/metabolism [MeSH], Ethylene Glycols [MeSH], Apolipoproteins E [MeSH], Positron-Emission Tomography [MeSH], Alzheimer Disease/genetics [MeSH], Apolipoprotein E4/genetics [MeSH], Alzheimer Disease/metabolism [MeSH], tau Proteins/metabolism [MeSH], Biomedical Imaging, metabolism [Demyelinating Diseases], florbetapir, Ethylene Glycols, metabolism [Alzheimer Disease], Clinical Sciences, metabolism [Amyloid beta-Peptides], tau Proteins, Apolipoproteins E, Clinical Research, Alzheimer Disease, Acquired Cognitive Impairment, Humans, Cognitive Dysfunction, ddc:610, Amyloid beta-Peptides, Biomedical and Clinical Sciences, Neurosciences, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Alzheimer's Disease Neuroimaging Initiative, metabolism [tau Proteins], Brain Disorders, 4.1 Discovery and preclinical testing of markers and technologies, metabolism [Brain], Positron-Emission Tomography, Dementia, diagnostic imaging [Alzheimer Disease], Demyelinating Diseases

    Dateibeschreibung: application/pdf

  18. 18
  19. 19
  20. 20

    Quelle: Eur J Nucl Med Mol Imaging
    Young, P, Heeman, F, Axelsson, J, Collij, L E, Hitzel, A, Sanaat, A, Niñerola-Baizan, A, Perissinotti, A, Lubberink, M, Frisoni, G B, Zaidi, H, Barkhof, F, Farrar, G, Baker, S, Gispert, J D, Garibotto, V, Rieckmann, A & Schöll, M 2023, 'Impact of simulated reduced injected dose on the assessment of amyloid PET scans', European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06481-0
    European journal of nuclear medicine, vol 51, iss 3

    Dateibeschreibung: application/pdf